Method of preparing benzodiazepinone derivatives or their salts

专利摘要:
Compounds of the formula <IMAGE> wherein R1 is alkyl of 3 to 12 carbon atoms; unsaturated aliphatic hydrocarbyl of 3 to 20 carbon atoms comprising 1 to 3 double bonds and/or one triple bond; phenyl(alkyl of 2 to 4 carbon atoms); methylenedioxybenzyl; chlorobenzyl; indan-5-ylmethyl; indan-3-ylmethyl; phenyl(alkenyl of 2 to 4 carbon atoms); cycloalkyl of 5 to 7 carbon atoms; (cycloalkyl of 3 to 10 carbon atoms)methyl; (methylcycloalkyl of 4 to 11 carbon atoms)methyl; morpholino(alkyl of 2 to 3 carbon atoms); pyrrolidino(alkyl of 2 to 3 carbon atoms); piperidino (alkyl of 2 to 3 carbon atoms); 4-methylpiperazino(alkyl of 2 to 3 carbon atoms); or, when R3 and/or R4 are methyl or ethyl, also methyl or ethyl; R2 is hydrogen, methyl or ethyl; and R3 and R4 are each hydrogen, methyl or ethyl; and non-toxic, pharmacologically acceptable acid addition salts thereof. The compounds as well as the salts are useful as anti-ulcerogenics and secretion inhibitors.
公开号:SU772484A3
申请号:SU782619956
申请日:1978-05-30
公开日:1980-10-15
发明作者:Шмидт Гюнтер；Лейтольд Матиас
申请人:Др.Карл Томэ Гмбх (Фирма)；
IPC主号:

专利说明:

 This invention relates to a process for the preparation of novel benzodiazepinone derivatives having valuable headlamp macologic properties. . The purpose of the invention is to obtain new, useful compounds expanding the arsenal of means of action on a living organism, is achieved by synthesizing the latter, based on the known amination reaction of haloalkyls with secondary amines l. The reaction is usually carried out in indiffe.
- straight or branched R, branched C, and -C 2 -alkyl group, Ce, -02-carbon-25 hydrogen radical with 1 to 3 double bonds and / or a triple bond, phenylalkyl group with 2 to 4 carbon atoms in alkyl-30
methylenedioxybenzyl group, chlorobenzyl group, indan-5- (or-3) -methyl group, phenylalkenyl group with 2–4 carbon atoms, cycloalkyl group with 5–7 atoms of enzyme solvent (alcohols, dioxane, toluene and others) in the presence of-. WIE hydrogen halide binder at a temperature from room temperature to the boiling point of the solvent. An excess of secondary amine or an alkali metal carbonate or bicarbonate is used as a hydrogen halide binder. A method for the preparation of benzodiazepinone derivatives of the general formula I carbon is proposed, a cycloalkylmethyl group with 3-10 atomic carbon in the cycloalkyl ring, unsubstituted or substituted by E1-methyl-morpholino, pyrrolidinopiperidine- or 4-methylparazinoalkyl group with 2 or 3 carbon atoms in the alkyl radical. Il cinnamradical; Rj is a hydrogen atom, methyl, ethyl radical; RaH is the same or different, hydrogen atom, methyl, fl radical; A is an unbranched or developed C.-Cd-alkylene radical, and if A о starts an unbranched sludge branched C2 C5 - an alkylene group, then Rj can also mean a hydrogen atom, methyl, ethyl il benzyl, ecl.R , and / or R means methyl or ethyl, then R. can also mean methyl or ethyl radical, or their salts, which means that the compound of the general formula | T c o-A-Hal where RgH A has the indicated values H is a halogen atom , is subjected to interaction with the compound (Niem of the general formula III, K3; where R, R, HR have the indicated meanings. The target product is isolated in in free state or as salt The reaction is preferably carried out in an indifferent solvent medium B at a temperature from room temperature to the boiling point of the solvent. Alcohols such as ethanol, N-propanol, isopropanol, ketones, such as acetone, or ethers, are suitable as solvents. such as dioxane or tetrahydrofuran, aromatic hydrocarbons, such as benzene or toluene. It is advisable to carry out the reaction in the presence of a hydrogen halide binding agent, such as carbonate or bicarbonate. an alkali metal, a tertiary organic amine, such as, for example, triethylamine, pyridine or dimethylaniline, or an excess of a compound of formula SH is obtained by reacting a compound of general formula I with an inorganic or organic compound; lot) H ;, such as, for example, Sol; Hydromide, chamois, phosphorus, vinna, fumarova, lemon, maleic, amber or oxalic. Example 1. 5,11-Dihydro-11-4- (2-methylallyl) -1-piperazinyl-acetyl-bH-pyrido 2, H-L 1,4 benzodiazepin-b-one. 8.62 g of 11-chloroacetyl-5,11-dihydro-bH-pyrido 2, 3-L 1.4 benzodiazepine-b-it, 3.5 g of sodium carbonate and 4.6 g of 1- (2-methylallyl) - piperazine in 100 ml of absolute ethanol is heated under reflux for 2 hours. Sucked in a hot state, the filtrate is evaporated to approximately 40 ml and cooled. The resulting crystals are recrystallized from ethanol by the addition of activated carbon; m.p. 205-207 0; yield 75% of theoretical. Example 2. Dihydrochloride. 5,11-DIHIDRO-11- I 4- (3-methyl-but-2-enyl) -1-piperazinyl-acetylJ-bH-pyrido 2,3-b 1,4 benzodiazepin-6-one. 8.62 g of 11-chloroacetyl-5,11-dihydro-BT-1-pyrido 2, W-1, 4 benzodiazepine-b-it, 3.5 g sodium carbonate and 5.07 g 1- (W-methylbutyl -2-enyl) piperazine (H -CH2-CH C (CH,) 2) in 100 ml of isopropanol is heated under reflux for 2.5 hours. Sucked off in a hot state, the filtrate is evaporated to 40 ml and cool. The resulting crystals are dissolved in 100 ml of absolute ethanol with heating and the calculated amount of concentrated hydrochloric acid is added. Upon cooling, the dihydrochloride crystallizes out; m.p. 208211 ° C; yield 70% of theoretical. Example 3. 5, ll-dihydro-ll-4- (2, 2-dimethylpropyl) -1-piperizinyl-acetyl-bH-pyrido 2 ,, 4 benzodiazepin-b-one. 7.15 g of 11-chloroacetyl-5,11-dihydro-bH-pyrido 2, 3-1,4 1,4 benzodiazepin-b-she, 2.9 g of potassium carbonate and 4.5 g of 1- (2,2-dimethylpropyl ) -piperazine in 100 ml of absolute ethanol is heated under reflux for 5 hours. Sucked off in a hot state. The crystals obtained from the filtrate are recrystallized from isopropanol using activated carbon; m.p. 232-234 °; yield 40% of theoretical. Example 4. 11- (4-ALLYL-1-piperazinyl) -acetyl-5,11-dihydro-bH-pyrido 2, 3-b 1,4 benzodiazepin-6-one. 8.62 g of 11-chloroacetyl-5,11-dihydro-6H-pyrido 2, 3-L 1, 4 benzodiazepine-b-she and 8.3 g of 11 -.allylpiperazine in 100 ml of ethanol are heated under reflux for 2 hours. The reaction mixture is evaporated, the crystalline residue is recrystallized from 30 ml of isopropanol and then from 94% ethanol, using activated carbon; m.p. 230-233 °; yield 47% of theoretical.
Example 5. 11- (n-but-2-enyl) -1-piperazinyl-acetyl} -5, 11-dihydro-bH-pyrido 2,3--1,4 benzodiazepine 6-one dihydrochloride dihydrate
8.62 g of 11-chloroacetyl-5,11-dihydro-bH-pyrido 2, 4 benzodiazepine-b-one and 8.7 g of 1- (n-but-2-enyl) piperazine (R - CHj CH CH-CH ,,) in 100 ml of dioxane is heated with an oepaTBhtt cooler for 3 hours and then evaporated in vacuo. The residue is purified on a column of silica gel and the oily base is dissolved in 70 ml of isopropanol in a hot state. Hydrochloric acid is acidified, and the dihydrochloride crystallizes out. Recrystallize from 94% -nog ethanol. The resulting crystals contain 2 moles of water of crystallization and melt at 207-210 ° C. Output 35% of theoretical.
Example b. Dihydrochloride 5, AND-dihydro-I- (4-nera-1-piperazinyl) -acetyl 3-bH-pyrido 2, 3-Ь 1/4 benzodiazepin-b-she.
Prepared from 5.8 g of 11 chloroacetyl-5, 11-dihydro-bH-pyrido12, 41benzodiazepin-6-one, 2.4 g of sodium carbonate and 5.3 g of 1-nerylpiperazine in 100 ml of absolute ethanol as described in Example 1 method. The resulting crude product is purified, on a column of silica gel and in absolute ethanol, with concentrated hydrochloric acid, converted into the dihydrochloride salt. Recrystallize from absolute ethanol; m.p. 188-191c; yield 65% of theoretical.
Example 7. 5,11-Dihydro-11-4- (about-methylbenzyl) -1-piperazinyl-acetyl-b H-pyrido 2, H-hl, 4 benzodiazepin-b-he.
5.8 g of 11-chloroacetyl-5,11-dihydro-bH-pyrido 2,3-b 1,4 benzodiazepine-b-it, 3-jitn triethylamine and 4.2 g of 1- (oL-methylbenzyl) piperazine
/. ,
stir in 40 ml
dioxane at 80 ° C for 2 hours. The dark solution is evaporated in vacuo and the residue is taken up in chloroform / water and extracted by shaking. The organic phase is purified with active charcoal, dried with sodium sulfate and evaporated in vacuo. The residue is recrystallized from a mixture of ethyl acetate and cyclohexane; m.p. 20420b; exit 62. from theoretical. , Example 8 5,11-Dihydro-11-4- (2-morpholinoethyl) -1-piperazi, nyl-acetyl-bH-pyrido. 2 W-1, 4 benzidazepip-6-one .
Prepared from 8.62 i-i 1 chloroG1, ethyl 5, 11-dihydro-bH-pyrido 2, H-L 1.4 benzodiazepin-b-one, 3.5 g of sodium carbonate and 6.1 g of 1- ( 2-morpholinoethyl) -piperazine in 100 ml of absolute ethanol as described in Example 1; m.p. 227-229C (from H-propanol); yield 63% of theoretical.
Example 9. 11-C4- (1-Ldamantylmethyl) -1-piperazinyl} -acetyl-5, 11-dihydro-bH-pyrido 2,3-b 1,4 benzodiazepin-b-on. , Obtained from 4.4 g of 11-chloroacetyl-5, 11-dihydro-bH-pyrido 2, 3- 1/ 1/4 benzodiazepine-b-one, 1.8 g of sodium carbonate and 3.75 g of 1- (l- adamantylmethyl) 5 -piperazine in 80 ml of absolute ethanol as in example 1.
Recrystallized from a mixture of N-propanol and dimethylformamide / so pl. 284-287 ° С with decomposition, yield 64% 0 of the theoretical.
Example 10. 5,11-Dihydro-11-5 4- (3,4-methylenedioxybenzyl) -1-piperazinyl-acetyl-bH-pyrido 2, 3-b} 1,4 benzodiazepin-b-on.
5 8 g of 11-chloroacetyl-5,11-dihydro-bH-pyrido 2, 3-bJ l, 4 benzodiazepine-b-she and 14 g of 1- (3,4-methylenedioxybenzyl) -piperazine in 400 ml of absolute benzene are heated with reverse
0 under reflux for 18 hours. The cooled reaction mixture is mixed with ethanol, made basic with ammonia and evaporated in vacuo. The residue is recrystallized from aqueous iso-propanol and then from isopropanol; m.p. 192-193 °; yield 51% of theoretical.
Example 11. Hydrochloride 5, AND-dihydro-And- (2, 4-dimethyl-1-pi-0-rasinyl) -acetyl-bH-pyrido 2, 3-b 1,4 benzodiazepin-b-she.
8.6 g of 11-chloroacetyl-5,11-dihydro-bH-pyrido 2, 3-3 1f 4 benzodiazepine-b-it, 3.1 g of sodium carbonate and
5 4.5 g of 1,3-dimethylpiperazine in
100 ml of absolute ethanol is heated under reflux for 3.5 hours. After suction, the filtrate is evaporated to dryness. The residue is purified
on a column of silica gel. Ethanol and hydrochloric acid are added to the base. After recrystallization from ethanol, hydrochloride is obtained with a mp. 301-303 ° C; yield 20% of theoretical.
Example 12. 5,11-Dihydro-5-methyl-11-4- (3,4-methylenedioxybenzyl) -1-piperazinyl-acetyl-bH-pyrido 2, 4 benzodiazepin-b-on. Prepared from 4.4 g of 11-chloroacetyl-5, 11-dihydro-5-methyl-6H-pyrido 2, 3-Ü 1, 4 benzodiazepin-b-one, 3.8 g of sodium carbonate, and 8 g of 1- ( 3,4-methylenedioxy) -benzyl-piperazine in 200 ml of absolute ethanol as in example 1 / so pl. 200-202 ° C
(from ethanol), a yield of 52% of theoretical.
Example 13. 5,11-Dihydro-11-z- (4-prenyl-1-piperazinyl) propionyl 6H-pyrido 2, 3-Ü 1, 4 benzodiazepine 6-one.
6.6 g 11 (3-chloropropionyl) -5,11-dihydro-bN-pyrido (2, 3-1/ 1/4 benzodiazepin-6-one, 2.56 g of sodium carbonate and 4.0 g 1-prenylpiperazine in 90 ml of absolute ethanol is heated under reflux for 2 hours, sucked off in a hot state and the filtrate is evaporated to 20 ml The crystalline precipitate is sucked off and recrystallized from isopropanol, mp 199-201 ° C, yield 62% of theoretical.
Example 14. (4-Benzyl-1-piperazinyl) propionyl - 5, 11-dihydro-BM-pyrido 2, 1, 4 benzodiazepia-b-on.
8.0 g of 11- {3-chloropropionyl) -5.11 Dihydro-bN-pyrido 2, 3- b 1,4 benzodiazepkn-b-she and 30 ml of 1-benzylpiperazine in 100 g-isopropanol are heated with a reverse fridge in for 1 hour Vacuum is evaporated to dryness, a solution of caustic soda is added to the residue, and the base is extracted with chloroform. Chloroform was distilled off and the residue was recrystallized from xylene, so pl. 205-207 ° C; m.p. dihydrochloride 212-214 ° C (methanol); yield 18% of theoretical.
Pp to m ro 15. 5,11-Dihydro I-3- {1-pyglerazinyl) -propionyl-bH-pyrido 2,3-b 1,4 benzodiazepine b - it.
To a boiling solution of 8.6 g of piperazim in 50 NUI of ethanol, while stirring, a warm solution of 6.0 g of 11- (3-chloropropionyl-5,11-dihydro-bH-pyrido 2, 4 benzodiazepages) is added dropwise. - it is in 12 ml of dimethyl acetamine G and a 40 l of ethanol. Then it is heated with reflux: -: m refrigerator for 1 hour. 1-3 hours the evaporation is evaporated to dryness and the residue is purified on a column of silica gel. The residue is evaporated to dryness and the residue is recrystallized from acetonntril, mp 280-282 ° C (decomposition); yield 70% of theoretical.
Example 16. 5,11-Dihydro-11 3 1- (2-phenylethyl) -1-piperazinyl-n -Gonconyl-6H-pyrido 2, H-b 1,4 benzodiazopine 6-one.
5.4 g of 11- (3-chloropropionyl) -5-11-dihydro-bN-pyrido 2,3-b 1,4 benzodiazepine-b-she and 3.8 g of 1- (2-phenylethyl) piperazine are stirred in 25 ml of dioxane for 2.5 hours at. The red colored solution was evaporated to dryness, the residue was dissolved in a mixture of chloroform and sodium bicarbonate solution, and the chloroform phase was evaporated in vacuo. The residue is recrystallized twice from H-propanol; m.p. 192-194 °; yield 65% of theoretical.
Example 17. 5,11-Dihydro-5-methyl-11- 2- (4-methyl-1-piperazinyl) -propionyl-6H-pyrido 2, H-L 1, 4 ben5 zodiazepin-6-one.
9.5 g 5-methyl-11- (2-chloropropionyl) -5, ll-dihydro-6H-pyrido 2, H-L 1.4 benzodiazepin-6-one, 3.2 g sodium carbonate, and 4 ml 1- Meel tilpiperzine in 120 ml of ethanol is heated under reflux for 7 hours. Sucked off in a hot state, the filtrate is concentrated to; 50 ml and a crystalline precipitate is separated. The filtrate is evaporated to dryness and the residue is recrystallized from isopropanol; m.p. 206-208 ° C, yield 36% of theoretical.
P. Example 18. 5,11-DIGIDRO-11- 4- (4-methyl-1-piperao-zinyl) -butyryl-6H-pyrido 2, H-B 1,4 benzodiazepin-6-one dihydrate fumarate.
6 g of 11- (4-chlorobutyryl) -5,11-dihydrr-6H-pyrido 2, 3-B 1.4 benzodiazepine-b-on and 6 g of 1-methylpiperazine
5 in 200 ml of absolute dioxane is heated under reflux for 1 h, sucked off in a hot state, the filtrate is evaporated to dryness in vacuum, the residue is washed with water and
0 purified on a column of silica gel. The resulting base with the calculated amount of fumaric acid is boiled for 3 hours in 60 ml of ethanol. After cooling, the release of dihydrogen fume, rat. Recrystallize from this: nola; m.p. 199-201s (with decomposition); access 31% of theoretical.
Example 19. 5,11-Dihydro-11-. (4-methyl-1-piperazinyl) -valeryl-bK-pyrido 2 ,, 4 benzodiazepin-b-one.
5.0 g of 11- (5-chloro-valeryl) -5,11-dihydro-bH-pyrido 2, 3-Ь 1,4 benzodiazepin-6-one, 1.6 g of sodium carbonate and 3 ml of 1-methylpiperazine in 100 ml
5 ethanol is heated under reflux for 20 hours. Sucked in a hot state, the filtrate (It is evaporated to dryness and the residue is purified on a column of silica gel, mp 1510 153 ° C. After recrystallization from ethyl acetate); yield 37% from theoretical.
Specified in the examples 5,6,11,15, 18,19, the purification of the crude product on a column of silica gel was carried out with pri-. by changing the mixture of chloroform, methanol, cyclohexane and concentrated ammonia in the ratio 68: 15: 15: 2 as a solvent and eluent. Analogously to examples 1-19, the compounds of Table 1 were obtained. New compounds: A 5,11-dihydro-11-J 4- (2-methylallyl) -1-piperazinyl-acetylJ-6H-pyrido 2, H-L 1.41 benzodiazepine 5-6-one; B dngndrochloride 5,11-dihydro-II-A- (3-methyl-but-2-enyl) -1-pipa razinyl-acetyl-6H-pyrido 2,, 6enzodiazepin-6-one; B 5,11-Dihydro-11-C4- {2,2-dimethylpropyl) -1-piperazinyl-acetyl-bH-pyrido 2, 3-fl, 4 benzodiazepine-6-one; G 11-I 4- (1-adamantylmethyl) -py-pera-vinyl-acetyl} -5,11-dihydro-bH-pyrido 2, 4 benzodiazepin-b-on; D 5,11-Dihydro-11-5 4- (3,4-methyl-di-dioxibenzyl) -l-piperzinyl-acetyl-bH-pyrido 2, 4 benzodiazepin-b; E hydrochloride 5, I-dihydro-I-{2,4-dimethyl-1-piperazinyl) -acetyl-b-pyrido 2, 4 benzodiazepine-b-one; W 5,11-dihydro-5-methyl-11-4- (3, 4-methylenedioxy6enzyl) -1-piperazinyl-acetyl-6H-pyrido 2, 3-3 l, 4 benzodiazepin-6-one; 3 11- (4-tinamoyl-1-piperazinyl) -acetyl-5,11-dihydro-bH-pyrido 2, 1.41 benzodiazepin-b-one; And (4-benzyl-1-piperazinyl) -propionyl-5, -11-dihydro-bH-pyrido 2,3-l 1,4 benzodiazepin-b-one; K 5,11-dihydro-11-p-4- (2-phenylethyl) -l-piperazinyl-propionyl-bH-pyrido 2, 3-s3 TI, 4 benzodiazepin-6-one were investigated for the effect that inhibits the formation of caused by stress in rats, and an antispasmodic effect, with respect to atropine, taking into account acute toxicity. Testing of the effect of inhibiting ulceration. Fed rats with a body weight between 220 and 260 g are individually sown in small wire cages and then placed in an upright position in a water bath at a constant temperature for 16 hours, so that only the head and the stern are on the surface of the water. The active substances were given orally to the rats 5-10 minutes before immersion in water. For each substance, 5 animals were taken. Control animals in the same way received 1 ml of 0.9% physiological saline solution or 1 ml of 1% tylose solution. After 18 h, the rats were killed with an overdose of chloroethyl, the stomach was taken out, opened along the greater curvature, and stretched on a cork plate. The antispasmodic effect was determined in a test tube on a thick guinea pig. Acetylcholine was used to create a spastic condition, and atropinsulfate was used for comparison. The spasmodic was given for 1 minute before giving an antispasmodic, the time of the action of the antispasmodic was 1 minute. It was also possible to observe in rats that atropine-like side effects, such as inhibition of the secretion of saliva, are completely absent during the administration of substances or substantially reduced. Acute toxicity was determined after oral administration of the active substances on unfed white breaths weighing 18–20 g. Time to observe - 14 days. For each dose, a group of 6 grisha was taken. The results of the experiments prkveden B table. 2. The antispasmodic effect of veshs-STB A-K compared with atropine sulphate is significantly weaker, along with it the side effects that are less characteristic of atroptnu. Table 1
HH,
-sn, (iH
21
CH :.
-sn -sn,., - sn ,,
22
Mz
-СИ 23 - On- ciHj -tiHj
Tic 8
(aqueous isopropanol)
44
The dihydrochloride 239-241, decomp. {absolute ethanol)
53
The dihydrochloride 240-242, decomp. (ethanol)
48
Dihydrochloride hydrate 210-213 absolute ethanol)
- dH. - (SNg
Prolong (Table 1)
H 248-250 (ethanol) 34
.i :: T.2
 -CH "-CH CH,
-SN
-SN
-en2-th (n;
- CH,
CHj
46 - dH-yn sng
—sn 47- (CHj),
-sn (iH,
48 - (iHz-ciH ci
49- (CH2) -CH n, dHj
II-si
50
((;-( iHrdHi-CH.e- (iH3 2
(geranip CH, CHj
5 -CHr 5HriH HriHr- - "-: Kj -sn
/ citronelly
Cjhlili
- (JHr M ri-CHr (
: Young-with
52
Sn „Hjri- c
d- d cJH-dH2
(sfiapHesufl i
CHj about dHj dHj - (YNLgSn- {Cis) Mr.
-riHzH .d I -CH.
1 -1h .. / H "-. h
6
7-Cng-with ng-L-CK.- dHj-yng-ch 58
- (Yng)
П 2Лцзлгени .... 1 ...
-4-T 5 G
СН, Н Н 16Т-166 (aceto-nitrile)
H H and 248-250 (H-Pro 61 pan)
H and H 135-140 hydro-65 chloride 250-252, decomp. (dpmetilforgiamid)
NII 140-142 (acetic 51 ether / cyclohexane)
INN Dihydrchloride-hydrate- 62 prat 216-218 (abs. Ethanol)
And H N Dihydrochloride 229- 58 233, decomp. (Abs. Ethanol)
INN Dihydrochloride-hydra-40 rat 231-234, razl (methanol)
INN Dihydrochloride 188-71 190, decomp. (abs. ethanol)
H N H Dihydrochloride 200-68,204, decomp. (ethanol)
SI N N Dihydrochloride. 208- ,, 61 210 (isopropanol)
H Dihydrochloride 180, 75 dec. Khabs. ethanol)
194-197 (acetic acid 36)
238-240 (M-prop 61
NOL)
Dihydrochloride hydrate 209-212 (ethanol) 47
H Hydrochloride 263- 68 264 (N-propanol1
H 173-175 (H-prop-67
sn. nol)
H 210-212 (M-propa-64 nol)
Continued table. one
772484
17
6 animals died. .
6 ANIMALS died.
6 animals. Died.
6 animals died. 6 animals died. 6 animals died.
18 Continued table. 2

权利要求:
Claims (3)
[1]
Invention Formula
1. A method for producing benzodiazepinone derivatives of general formula I
g
K. -BI
unbranched or section R
35 branched Ce, -CS alkyl group, C-C o-hydrocarbon scraper with 1-3 double bonds and / or triple bond,
40 phenylalkyl group with 2-4 carbon atoms in the alkyl radical, methylenedioxybenzyl group, chlorobenzyl group. a group, indan-5- (or-3) 45 -methyl group / phenylalkenyl group with 2-4 carbon atoms, cycloalkyl group with 5-7 carbon atoms,
50 cycloapkylmethyl group with 3-10 carbon atoms in the cycloalkyl ring, unsubstituted or substituted by methyl, morpho
55 LINO-, pyrrolidino-, piperidino- or 4-methylpiperazinoalkyl group With 2 or 3 carbon atoms in the alkyl radical, or cinnamyl radical: 60 hydrogen atom, methyl,
R, ethyl radical;
R and R. are the same or different, hydrogen atom, methyl,
65 ethyl radical;
A is an unbranched or branched C-C -alkylene radical, and if A means an unbranched or branched C2-Su-alkylene group, then R can also mean a hydrogen atom, methyl, ethyl or benzyl and, if RJ and / or R means methyl ethyl, then R can also mean methyl or ethyl,
salts thereof, characterized in that the compound has the general form (JO-A-HOI where R and A have the indicated meanings and
Hal is a halogen atom, is reacted with a compound of general formula 11
RS
vn
 J K
where R, R-, and R have the indicated en-e following the modification of the desired product in free form or as a salt.
.
2. The method according to claim 1, that is, so that the reaction is carried out in an environment of an indifferent solvent at a temperature from room temperature to the boiling point of the solvent.
[2]
3. The method according to claims 1 and 2, characterized in that the reaction is carried out
[3]
in the presence of a hydrogen halide binding agent
The hydrogen halide agent, carbonate alkali carbonate or bicarbonate4. The method according to the reference point, the metal and the tertiary organic and the fact that as an amine.
hydrogen halide agent is used
The excess compound of formula Iji.5 is taken into account in the examination
5. The method according to claim 3, distinguish -1. Patent of the USSR 567407, soup, and with the fact that as a bond-cl. C 07 O 243/38, 1974.

类似技术:

---

公开号 | 公开日 | 专利标题

---

US4379150A|1983-04-05|Dibenz[b,f][1,4]oxazepine derivatives, process for preparing the same, and pharmaceutical compositions comprising the same

---

US4675319A|1987-06-23|Antianaphylactic and antibronchospastic piperazinyl-|carboxamides, compositions and use

---

SU772484A3|1980-10-15|Method of preparing benzodiazepinone derivatives or their salts

---

US3466287A|1969-09-09|1-|-lower-alkyl)-4-substituted piperazines

---

PL69767B1|1973-08-31|11-substituted 5 11-dihydro-6h-pyrido|benzodiazepin-6-ones [us3660380a]

---

CA1193264A|1985-09-10|Pharmaceutically active |bibenzylderivatives

---

IE70927B1|1997-01-15|New | piperazine derivatives process for preparing these and pharmaceutical compositions containing them

---

SU797578A3|1981-01-15|Method of preparing benzodiazepinone derivatives or their salts

---

US3705907A|1972-12-12|4-|-3-aminopropoxy)-indole derivatives

---

US5116995A|1992-05-26|Carbazole compounds

---

US4254031A|1981-03-03|Synthesis for the preparation of tetracyclic compounds

---

CZ295068B6|2005-05-18|Novel substituted [2-|ethoxy]methyl compounds

---

FI63029B|1982-12-31|EXAMINATION OF N-SUBSTITUTES FOR THE EXTRACTION OF NUTRITIONAL 5,11-DIHYDRO- | -6H-PYRIDO | | -BENZODIAZEPIN-6-ON DERIVATE

---

US3634420A|1972-01-11|3|-2 3-dihydro-carbazol-4|-ones

---

US3696120A|1972-10-03|4-|-indole derivatives

---

US4267328A|1981-05-12|1-Phenylpiperazines

---

EP0012208A2|1980-06-25|9-|propyl)-carbazole, its preparation and pharmaceutical compositions containing it

---

SU428602A3|1974-05-15|METHOD OF OBTAINING BASIC-SUBSTITUTE DERIVATIVES 1

---

FR2522000A1|1983-08-26|NOVEL THIOPYRANNOPYRIMIDINES, PARTICULARLY USEFUL AS HYPOGLYCEMIC AGENTS, AND THEIR MANUFACTURE

---

PL69663B1|1973-08-31|

---

US4217452A|1980-08-12|Synthesis for the preparation of tetracyclic compounds

---

US3963778A|1976-06-15|Basic oximes and their preparation

---

GB2101990A|1983-01-26|Isocarbostyril derivatives

---

US4224321A|1980-09-23|Biologically active tetracyclic compounds and pharmaceutical compositions containing same

---

US4904688A|1990-02-27|Tricyclic amine derivatives

同族专利:

---

公开号 | 公开日

---

BG26949A4|1979-07-12|

---

PT68112A|1978-06-01|

---

SE7806288L|1978-12-01|

---

HK11182A|1982-03-19|

---

FI63232B|1983-01-31|

---

PL207191A1|1979-07-16|

---

US4213984A|1980-07-22|

---

IE781071L|1978-11-30|

---

AT361491B|1981-03-10|

---

FR2392993B1|1981-06-26|

---

IE46907B1|1983-11-02|

---

DE2724434A1|1979-02-22|

---

AU516893B2|1981-06-25|

---

DK239578A|1978-12-01|

---

ATA367878A|1980-08-15|

---

ZA783084B|1980-02-27|

---

NZ187426A|1981-10-19|

---

BE867638A|1978-11-30|

---

CA1109064A|1981-09-15|

---

PL113628B1|1980-12-31|

---

FI63232C|1983-05-10|

---

FI781474A|1978-12-01|

---

DD137106A5|1979-08-15|

---

ES473441A1|1979-05-01|

---

IL54813A|1982-02-28|

---

GB1571781A|1980-07-16|

---

PL112911B1|1980-11-29|

---

JPS543096A|1979-01-11|

---

IL54813D0|1978-07-31|

---

NO149313C|1984-03-28|

---

FR2392993A1|1978-12-29|

---

NL7805847A|1978-12-04|

---

NO781878L|1978-12-01|

---

AU3662278A|1979-12-06|

---

MY8200242A|1982-12-31|

---

PL214169A1|1979-11-05|

---

NO149313B|1983-12-19|

---

PH14609A|1981-10-02|

---

GR66164B|1981-01-20|

---

CS207617B2|1981-08-31|

---

CH637652A5|1983-08-15|

---

ES470270A1|1979-01-01|

---

HU180999B|1983-05-30|

---

BG28711A3|1980-06-16|

引用文献:

---

公开号 | 申请日 | 公开日 | 申请人 | 专利标题

---

---

DE1795183B1|1968-08-20|1972-07-20|Thomae Gmbh Dr K|5,11-dihydro-6H-pyrido [2,3-b] [1,4] benzodiazepin-6-one derivatives and drugs|GB2053187A|1979-07-09|1981-02-04|Grissmann Chem Ltd|Process for preparing pyrenzepine|

---

IT1130973B|1980-03-17|1986-06-18|Microsules Argentina Sa De S C|PROCESS FOR THE PREPARATION OF DERIVATIVES OF 5,11-DI-HYDRO-6H-PYRID -BENZODIAZEPIN-6-ONE, FINAL AND INTERMEDIATE DERIVATIVES OF SYNTHESIS IN THIS WAY OBTAINED|

---

DE3204403A1|1982-02-09|1983-08-11|Dr. Karl Thomae Gmbh, 7950 Biberach|NEW PYRIDOBENZODIAZEPINONE, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS|

---

DE3204401A1|1982-02-09|1983-08-11|Dr. Karl Thomae Gmbh, 7950 Biberach|PYRIDOBENZODIAZEPINONE, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS|

---

IT1212742B|1983-05-17|1989-11-30|Dompe Farmaceutici Spa|DIBENZO DERIVATIVES [1,4] PYRID DIAZEPINONIC [1,4] BENZODIAZEPINONIC, PYRID [1,5] BENZODIAZEPINONIC AND THEIR PHARMACOLOGICAL ACTIVITY|

---

DE3726908A1|1987-08-13|1989-02-23|Thomae Gmbh Dr K|NEW CONDENSED DIAZEPINONE, PROCESS FOR THEIR MANUFACTURE AND MEDICAMENTS CONTAINING THESE COMPOUNDS|

---

DE3820345A1|1988-06-15|1989-12-21|Thomae Gmbh Dr K|CONDENSED DIAZEPINONE, METHOD FOR THE PRODUCTION THEREOF AND MEDICAMENT CONTAINING THESE COMPOUNDS|

---

US5298508A|1988-07-19|1994-03-29|The United States Of America As Represented By The Department Of Health And Human Services|Irreversible inhibitors of adenosine receptors|

---

US5324832A|1991-07-03|1994-06-28|The United States Of America As Represented By The Department Of Health And Human Services|Muscarinic antagonists|

---

WO1997037667A1|1996-04-10|1997-10-16|The United States Of America, Represented By The Secretary, Department Of Health And Human Services|Use of an a1 adenosine receptor agonist to treat cerebral ischaemia|

---

CA2573674A1|2004-07-16|2006-01-26|Proteosys Ag|Muscarinic antagonists with parp and sir modulating activity as agents for inflammatory diseases|

---

EP2387405A2|2009-01-13|2011-11-23|ProteoSys AG|Pirenzepine as an agent in cancer treatment|

---

CN103242246A|2013-05-21|2013-08-14|苏州科捷生物医药有限公司|Synthetic method of 3-substituted N-methyl piperazine|

法律状态:

优先权:

---

申请号 | 申请日 | 专利标题

---

DE19772724434|DE2724434A1|1977-05-31|1977-05-31|NEW, 11-POSITION SUBSTITUTED 5,11-DIHYDRO-6H-PYRIDO SQUARE CLAMP ON 2.3-B SQUARE CLAMP ON SQUARE CLAMP ON 1.4 SQUARED CLAMP ON BENZODIAZEPIN-6-ONE, METHOD FOR THEIR PRODUCTION AND THESE CONNECTIONS DRUG|

---